Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $606.01 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ENDOTRONIX, INC. | $240.45 | 1 | $0 (2024) |
| Medtronic Vascular, Inc. | $116.46 | 1 | $0 (2019) |
| GE HealthCare | $114.64 | 3 | $0 (2023) |
| ABBVIE INC. | $96.18 | 5 | $0 (2024) |
| Biosense Webster, Inc. | $38.28 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $276.46 | 3 | ENDOTRONIX, INC. ($240.45) |
| 2023 | $147.77 | 5 | GE HealthCare ($87.60) |
| 2021 | $27.04 | 1 | GE HEALTHCARE ($27.04) |
| 2020 | $38.28 | 1 | Biosense Webster, Inc. ($38.28) |
| 2019 | $116.46 | 1 | Medtronic Vascular, Inc. ($116.46) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | ENDOTRONIX, INC. | CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) | Food and Beverage | Cash or cash equivalent | $240.45 | General |
| Category: HEART FAILURE | ||||||
| 08/10/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/08/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/23/2023 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/16/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $55.21 | General |
| 05/16/2023 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $32.39 | General |
| 05/08/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/08/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/18/2021 | GE HEALTHCARE | — | Food and Beverage | Cash or cash equivalent | $27.04 | General |
| 02/19/2020 | Biosense Webster, Inc. | Carto 3 System (Device) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: Cardiology | ||||||
| 09/27/2019 | Medtronic Vascular, Inc. | Resolute (Device) | Food and Beverage | In-kind items and services | $116.46 | General |
| Category: Stents | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 97 | 138 | $42,028 | $13,181 |
| 2022 | 4 | 92 | 170 | $75,342 | $24,645 |
| 2021 | 4 | 115 | 224 | $110,099 | $36,712 |
| 2020 | 1 | 40 | 104 | $66,735 | $22,392 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 55 | $20,405 | $6,405 | 31.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 33 | 72 | $16,200 | $5,077 | 31.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,423 | $1,699 | 31.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 29 | 86 | $54,271 | $17,857 | 32.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 40 | $8,160 | $2,644 | 32.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 25 | $7,325 | $2,355 | 32.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 16 | 19 | $5,586 | $1,789 | 32.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 45 | 137 | $87,180 | $28,953 | 33.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 28 | $8,296 | $2,980 | 35.9% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 27 | 28 | $8,232 | $2,731 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 27 | 31 | $6,391 | $2,048 | 32.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 40 | 104 | $66,735 | $22,392 | 33.6% |
About Dr. Michael Devita, MD
Dr. Michael Devita, MD is a Hospice and Palliative Medicine healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1588636005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Devita, MD has received a total of $606.01 in payments from pharmaceutical and medical device companies, with $276.46 received in 2024. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($606.01).
As a Medicare-enrolled provider, Devita has provided services to 344 Medicare beneficiaries, totaling 636 services with total Medicare billing of $96,931. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Hospice and Palliative Medicine
- Other Specialties Critical Care Medicine, Critical Care Medicine
- Location New York, NY
- Active Since 02/07/2006
- Last Updated 12/09/2014
- Taxonomy Code 207RH0002X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588636005
Products in Payments
- CORDELLA PULOMONARY ARTERY PRESSURE SENSOR (Device) $240.45
- Resolute (Device) $116.46
- DALVANCE (Drug) $62.84
- Carto 3 System (Device) $38.28
- TEFLARO (Drug) $20.00
- AVYCAZ (Drug) $13.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospice and Palliative Medicine Doctors in New York
Dr. Raymond Pastore, M.d, M.D
Hospice and Palliative Medicine — Payments: $24,008
Dr. Richard Lin, M.d., Ph.d, M.D., PH.D
Hospice and Palliative Medicine — Payments: $12,139
Mohamed Amr Ahmed Hosny, M.d, M.D
Hospice and Palliative Medicine — Payments: $2,352
Lori Schleicher, Md, MD
Hospice and Palliative Medicine — Payments: $2,331
Julissa Baez, Md, MD
Hospice and Palliative Medicine — Payments: $2,141
Milagros Silva, M.d, M.D
Hospice and Palliative Medicine — Payments: $1,809